NCT04057755View on ClinicalTrials.gov

Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 15, 2016

Primary Completion Date

June 15, 2019

Study Completion Date

June 15, 2019

Conditions
Vulvodynia
Interventions
DRUG

botulinum toxin A

DRUG

NaCl

Trial Locations (1)

182 88

Danderyd Hospital, Dep. of Obstetrics and Gynecology, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT04057755 - Botulinum Toxin A as a Treatment for Provoked Vestibulodynia | Biotech Hunter | Biotech Hunter